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Abstract 
Prins desymmetrisation reactions of cyclohexa-1,4-diene derivatives have been investigated as a 
route to the core of the cladiellin diterpenes. During the course of this work, we observed the 
formation of a partially-reduced benzofuran 18, which is clearly derived from oxocarbenium ion 
21. This can only be rationalised by an unexpected primary to secondary silyl group migration. 
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Introduction 
 
We have recently reported model studies for the Prins desymmetrisation of cyclohexa-1,4-dienes 
to give systems related to the cladiellin diterpenes.1 In our initial work, compound 1 underwent a 
rather dramatic transformation into compound 2 by way of formation and reaction of an 
oxocarbenium ion followed by rearrangement. In this way, the core functionality and 
stereochemistry of the cladiellin diterpenes, for example 7-deacetoxyalcyonin acetate (3)2 was 
rapidly established (Scheme 1). 
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Scheme 1 
 
This reaction involves the double-deprotection of compound 1 to give intermediate 4, 
followed by formation of oxocarbenium ion 5, cyclisation to give 6 which rearranges to give 7 
and deprotonation/tautomerisation to give the product 2 (Scheme 2). 
 
 
Scheme 2 
 
In seeking to extend these studies, we elected to fuse an additional ring onto the precursor 
as shown in Scheme 3. While the fusion of an aromatic ring is appropriate for such a study, we 
envisage that eventually this will be replaced with a system that can be cleaved to give the 
complete cladiellin core. It was therefore envisaged that the Prins desymmetrisation of 
compound 8 would give rise to compound 9. 
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Scheme 3 
 
 
Results and Discussion 
 
It was envisaged that the key precursor 12 would be accessible by formation of an organolithium 
compound from 11 and then reaction with the epoxide 10 (Scheme 4). 
 
 
Scheme 4 
 
Compound 11 was prepared according to a literature method.3 Compound 10 was prepared 
as shown in Scheme 5. Birch reduction of benzoic acid followed by esterification gave 
compound 13. Deprotonation and acylation with methyl chloroformate was followed by lithium 
aluminium hydride reduction to give diol 15. Mono-silylation and Swern oxidation then gave 
aldehyde 17. Addition of bromomethyllithium to the aldehyde was rather troublesome. With an 
excess of bromomethyllithium complex mixtures of products were obtained. Therefore it was 
better to use only a slight excess. Under these conditions the reaction did not proceed to 
completion, but the unreacted aldehyde was readily removed by treatment of the crude reaction 
mixture with sodium borohydride prior to chromatography. This gave the desired epoxide 10 in 
satisfactory yield. 
Lithiation of compound 11 with t-BuLi for 10 minutes at -78 °C prior to addition of 
epoxide 10 initially appeared to have been successful. Purification gave a product in which the 
acetal had been retained along with a 1,2-disubstituted benzene ring, and that the epoxide had 
been opened. This was therefore subjected to the conditions of the Prins desymmetrisation 
(Scheme 6). It rapidly became clear that the product of this two-step process was the partially-
reduced benzofuran 18 rather than the desired product. The structural assignment of compound  
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Scheme 5 
 
18 was by no means straightforward. Extensive analysis of 1H and 13C NMR spectroscopic data, 
and 1H–1H and 1H–13C correlation data (COSY, HMBC and HSQC) enabled determination of the 
carbon-hydrogen framework connectivity. Mass spectrometric studies identified the presence of 
the two bromine atoms in the compound 18. The stereochemistry of compound 18 was assigned 
by analogy with that of related compounds.1b 
 
 
Scheme 6 
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In a previous study, we reported the formation of ketones during Prins desymmetrisation 
reactions.1b These arise by protonation of an acetal 19 on the more hindered oxygen followed by 
the Prins reaction, and compounds 20 were invariably the minor products (Scheme 7). In this 
case compound 14 was the only product formed, which suggests that if an acetal such as 19 is 
formed, it is opened regioselectively but in the “wrong” direction. This seems rather unlikely. 
 
 
 
Scheme 7 
 
However, since the structure of compound 18 is secure, it is clear that it must be formed 
from oxocarbenium ion 21 (R = H or TBS). Since it is unlikely that opening of an acetal forms 
this intermediate, the most likely explanation is opening of epoxide 10 by bromide derived from 
the partial lithiation of compound 11. 
 
 
 
Scheme 8 
 
In order to investigate this process further, the coupling of compounds 10 and 11 was 
repeated. Extensive chromatography led to the isolation of an epoxide-opening product that 
lacked the aromatic ring (Scheme 9). This was assigned structure 22 or 23, although we could 
not a priori deduce the location of the silyl group. Examination of the spectra from the previous 
coupling reaction showed that the same epoxide-opening product was present. As a result of the 
subsequent formation of compound 18, it seems overwhelmingly likely that the structure is 23 
and not 22, so that a silyl migration has taken place during the epoxide-opening. 
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Scheme 9 
 
Explaining this apparent silyl migration is not straightforward. While there are many 
examples of silyl groups migrating from secondary to primary alcohols in the literature,4 we 
could find no examples of primary to secondary migration, and we assume that such a process 
would be kinetically disfavoured. However, if we assume that the BF3 coordinates to the epoxide 
oxygen in order to assist the epoxide-opening, we can consider the intermediacy of a hypervalent 
silicon compound 26a (Scheme 10). The BF3 should then be readily transferred to the less-
hindered oxygen which will give intermediate 27a which should then undergo opening with 
effective silyl-transfer to give 29a. In fact, this process is very reminiscent of the regioselective 
opening of the corresponding acetals with Lewis acids.1 
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Scheme 10 
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Density functional theory calculations (Spartan 10, B3LYP 6-31+G*) have provided some 
insight into this transformation. For simplicity the calculations were carried out with a 
trimethylsilyl group in place of TBS. Both 26b and 27b minimise at this level of theory with 
cleavage of a Si-O bond, so that it was not possible to obtain minimum energy structures for 
these intermediates. However, a single-point DFT calculation based on a molecular mechanics 
minimised structure in each case indicated that 27b is considerably more stable than 26b (235 kJ 
mol-1, although since these numbers are not based on optimised structures, they should be 
interpreted cautiously) (Figure 1). In both cases the BF3 is axial to avoid severe steric 
interactions with the trimethylsilyl group. However, upon minimisation, the product 29b is more 
stable than 28b (by 11.6 kJ mol-1).  The lowest energy conformers of these two structures are 
shown in Figure 2. Therefore, we would tentatively attribute the formation of intermediate 29 as 
being due to rapid migration of the BF3 to the less-hindered oxygen.  
 
   
   -3807.72667 H    -3807.74829 H 
Figure 1. Spartan MMFF minimised structures of 26b and 27b, and single-point DFT (6-31+G*) energies. 
   
   -3807.90925 H   -3807.90484 H 
Figure 2.  B3LYP (6-31+G*) lowest energy conformers of 28b and 29b. 
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Conclusions 
 
The formation of compound 18 was unanticipated on the basis of our previous work. However, it 
can be rationalised as a result of an unexpected primary to secondary silyl migration as follows. 
Metal-halogen exchange on compound 11 generates bromide. Presumably the organolithium 
reagent is also formed, but the fate of this species is unclear. Boron trifluoride promotes the 
opening of epoxide 10 with bromide to generate intermediate 25a, which rearranges under the 
influence of the boron trifluoride to give the primary alcohol 23. Oxocarbenium ion 21 is then 
formed by reaction with 11, and cyclisation of this ion initially gives the secondary carbenium 
ion 30 before rearrangement to the more stable allylic carbenium ion 31. Loss of a proton will be 
followed by hydrolysis and tautomerisation of the silyl enol ether 32 to ultimately give the 
observed product 18. 
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Scheme 11 
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Experimental Section 
 
General. Melting points were determined on a Gallenkamp melting point apparatus. Infrared 
spectra were recorded on a Perkin Elmer 1600 FTIR spectrophotometer. Mass spectra were 
recorded on a Fisons VG Platform II spectrometer and on a Micromass Q-TOF Micro 
spectrometer. NMR spectra were recorded on a Bruker DPX 400 spectrometer operating at 400 
MHz for 1H and at 100 MHz for 13C at 25 °C, or on a Bruker Avance 500 spectrometer operating 
at 500 MHz for 1H and 125 MHz for 13C at 25 °C. All chemical shifts are reported in ppm 
downfield from TMS. Coupling constants (J) are reported in Hz. Multiplicity in 1H NMR 
spectroscopy is reported as singlet (s), doublet (d), double doublet (dd), double triplet (dt), 
double quartet (dq), triplet (t), and multiplet (m). Multiplicity in 13C NMR spectroscopy was 
obtained using the DEPT pulse sequence. Flash chromatography was performed using Matrex 
silica 60 35–70 micron. Solvents for moisture-sensitive reactions were dried by distillation; THF 
over sodium benzophenone ketal and CH2Cl2 over CaH2. Such reactions were carried out under 
an atmosphere of nitrogen. 
 
Ethyl cyclohexa-2,5-dienecarboxylate (13).5 Sodium metal (6.22 g, 270 mmol) was added in 
portions to a solution of benzoic acid (10.0 g, 81.9 mmol) in liquid NH3-EtOH (4:1, 500 ml) at -
78 °C. After the blue colour had faded, solid NH4Cl (17.5 g) was added and the ammonia was 
allowed to evaporate. The mixture was then acidified by addition of 2 M HCl and the aqueous 
layer extracted with Et2O. The combined extracts were dried (Na2SO4) before the solvent was 
removed in vacuo. The residue was re-dissolved in EtOH (250 ml) and treated with conc. H2SO4 
(~0.5 ml). The resulting solution was allowed to stir at room temperature for 16 h. The solvent 
was removed in vacuo and the reaction mixture neutralized by addition of saturated aqueous 
NaHCO3 solution. The aqueous layer was extracted with Et2O and the combined extracts dried 
over Na2SO4. The solvent was removed in vacuo affording the title compound 13 (9.23 g, 74%) 
as a pure colourless oil. IR: νmax (Nujol): 2981, 2873, 2821, 1735, 1366, 1179, 1034, 942 898, 
715 and 668 cm-1. NMR: δH (400 MHz; CDCl3): 5.90 – 5.86 (2 H, m, alkene CH), 5.84 – 5.79 (2 
H, m, alkene CH), 4.16 (2 H, q, J = 7.1, CH2O), 3.75 – 3.68 (1 H, broad m, CH), 2.71 – 2.66 (2 
H, broad m, CH2) and 1.27 (3 H, t, J = 7.1, CH3); δC (100 MHz; CDCl3): 172.6 (C=O), 126.3 (2 
× CH), 122.2 (2 × CH), 60.9 (CH2), 41.7 (CH), 25.8 (CH2) and 14.2 (CH3). 
1-Ethyl 1-methyl cyclohexa-2,5-diene-1,1-dicarboxylate (14). n-Butyllithium (13.2 ml of a 2.5 
M solution in hexanes, 32.9 mmol) was added dropwise to a solution of diisopropylamine (4.61 
ml, 32.9 mmol) in THF (50 ml) at 0 °C. The mixture was allowed to stir for 30 minutes at the 
same temperature before being cooled to -78 °C. The ester 13 (5.01 g, 33.0 mmol) was added 
dropwise and the reaction mixture allowed to stir for 30 minutes at -78 °C before methyl 
chloroformate (2.80 ml, 36.2 mmol) was added. The resulting solution was stirred for a further 
15 minutes at -78 °C before the reaction was quenched with saturated aqueous NH4Cl solution. 
The mixture was extracted with Et2O, the combined extracts being dried (Na2SO4) before the 
solvent was removed in vacuo. Chromatography on silica gel (Et2O: petroleum ether 1: 19) 
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afforded the title compound 14 (5.84 g, 84%) as a colourless oil. IR: νmax (neat): 2984, 2956, 
1735, 1436, 1251, 1205, 1064, 1038, 860, 801, 778 and 704 cm-1. NMR: δH (400 MHz; CDCl3): 
6.07 – 6.02 (2 H, m, alkene CH), 5.98 (2 H, app. dt, J = 10.4, 1.8, alkene CH), 4.20 (2 H, q, J = 
7.1, CH2O), 3.75 (3 H, s, OCH3), 2.72 – 2.70 (2 H, m, ring CH2) and 1.26 (3 H, t, J = 7.1, CH3); 
δC (100 MHz; CDCl3): 170.3 (C), 169.6 (C), 127.8 (2 × CH), 122.2 (2 × CH), 61.9 (CH2), 55.4 
(C), 52.9 (CH3), 25.9 (CH2) and 14.0 (CH3). 
Cyclohexa-2,5-diene-1,1-diyldimethanol (15). A solution of diester 14 (5.84 g, 27.8 mmol) in 
THF (20 ml) was added slowly to a suspension of LiAlH4 (2.11 g, 55.6 mmol) in THF (60 ml). 
The mixture was allowed to stir at room temperature for 2 h before being quenched by slow 
addition of aqueous 2 M NaOH solution. The solution was dried (Na2SO4), filtered and the 
solvent removed in vacuo. Chromatography on silica gel (EtOAc: petroleum ether 2: 1) afforded 
the title compound 15 (2.59 g, 67%) as a colourless solid, m.p. 82 – 84 °C. IR: νmax (Nujol): 
3399, 2923, 2855, 1633, 1252, 1100, 1023, 984, 940, 898 and 707 cm-1. NMR: δH (400 MHz; 
CDCl3): 6.09 – 6.04 (2 H, m, alkene CH), 5.60 – 5.56 (2 H, m, alkene CH), 3.52 (4 H, s, 2 × 
CH2O), 2.72 (2 H, app. tt, J = 3.4, 2.1, ring CH2) and 1.69 (2 H, broad s, 2 × OH); δC (100 MHz; 
CDCl3): 128.5 (2 × CH), 126.9 (2 × CH), 68.0 (2 × CH2), 44.6 (C) and 26.9 (CH2). 
[1-[(tert-Butyldimethylsilyloxy)methyl]cyclohexa-2,5-dienyl]methanol (16). n-Butyllithium 
(2.40 ml of 2.5 M solution in hexanes, 6.01 mmol) was added to a solution of diol 15 (886 mg, 
6.33 mmol) in THF (15 ml) at -78 °C. The resulting solution was allowed to warm to room 
temperature over 1 h before a solution of tert-butyldimethylsilyl chloride (859 mg, 5.70 mmol) in 
THF (5 ml) was added. The reaction mixture was stirred for 30 minutes before imidazole (cat.) 
was added. The resulting mixture was stirred for 16 h at room temperature before the reaction 
was quenched with saturated aqueous NaHCO3 solution. The mixture was extracted with Et2O, 
the combined extracts being dried (Na2SO4) before the solvent was removed in vacuo. 
Chromatography on silica gel (EtOAc: petroleum ether 1: 1) afforded the title compound 16 
(1.38 g, 86%) as a colourless oil. IR: νmax (Neat): 3419, 3028, 2954, 2929, 2885, 2857, 1635, 
1471, 1464, 1255, 1084, 1046, 940, 838, 776 and 708 cm-1. NMR: δH (500 MHz; CDCl3): 5.94 – 
5.91 (2 H, m, alkene CH), 5.62 (2 H, app. dt, J = 10.5, 2.0, alkene CH), 3.59 (2 H, s, CH2OTBS), 
3.54 (2 H, s, CH2OH), 2.70 – 2.68 (2 H, m, ring CH2), 2.17 – 1.87 (1 H, broad s, OH), 0.89 (9 H, 
s, t-Bu) and 0.04 (6 H, s, 2 × CH3); δC (125 MHz; CDCl3): 127.3 (2 × CH), 127.0 (2 × CH), 69.7 
(CH2), 69.1 (CH2), 43.6 (C), 27.1 (CH2), 25.8 (3 × CH3), 18.2 (C) and -5.6 (2 × CH3). MS-APCI: 
m/z (%) = 255 (M+H+, 100), 237 (21), 177 (17), 156 (7), 130 (6) and 105 (3). HRMS-APCI: m/z 
[M + H]+ calcd for C14H27O2Si: 255.1780; found: 255.1776. 
1-[(tert-Butyldimethylsilyloxy)methyl]cyclohexa-2,5-dienecarbaldehyde (17).6 Oxalyl 
chloride (0.59 ml, 6.89 mmol) was added dropwise into a solution of DMSO (1.12 ml, 15.7 
mmol) in CH2Cl2 (20 ml) at -78 °C. The solution was stirred for 10 minutes before the alcohol 16 
(499 mg, 1.96 mmol) was added dropwise. After stirring for a further 10 minutes at -78 °C, 
triethylamine (3.57 ml, 25.6 mmol) was added and the reaction mixture allowed to warm to room 
temperature over 2 h. The reaction was quenched by pouring into saturated aqueous NaHCO3 
solution. The crude product was extracted with CH2Cl2, the combined extracts being dried 
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(Na2SO4) before the solvent was removed in vacuo. Chromatography on silica gel (Et2O: 
petroleum ether 1: 49) afforded the title compound 17 (429 mg, 87%) as a colourless oil. IR: νmax 
(Neat): 3032, 2955, 2929, 2886, 2857, 1729, 1651, 1634, 1471, 1420, 1256, 1111, 1083, 839, 
778 and 704 cm-1. δH (400 MHz; CDCl3): 9.51 (1 H, s, aldehyde CH), 6.04 – 6.00 (2 H, m, 
alkene CH), 5.71 (2 H, app. dt, J = 10.5, 2.0, alkene CH), 3.76 (2 H, s, CH2OTBS), 2.74 – 2.72 
(2 H, m, ring CH2), 0.86 (9 H, s, t-Bu) and 0.03 (6 H, s, 2 × CH3). δC (100 MHz; CDCl3): 200.9 
(aldehyde CH), 128.3 (2 × CH), 122.7 (2 × CH), 67.3 (CH2), 55.3 (C), 27.0 (CH2), 25.7 (3 × 
CH3), 18.2 (C) and -5.6 (2 × CH3). 
tert-Butyldimethyl[[1-(oxiran-2-yl)cyclohexa-2,5-dienyl]methoxy]silane (10). n-Butyllithium 
(1.75 ml of a 2.5 M solution in hexanes, 4.37 mmol) was added to a solution of aldehyde 17 
(1.00 g, 3.97 mmol) and dibromomethane (0.42 ml, 5.95 mmol) in THF (30 ml) at -78 °C. The 
reaction mixture was warmed to room temperature and stirred for 24 h, before being quenched 
with saturated aqueous NH4Cl. The mixture was extracted with ether, the combined extracts 
being dried (Na2SO4) before the solvent was removed in vacuo affording a crude mixture of 
aldehyde and epoxide (aldehyde: epoxide ~ 2:7, 1.09 g). The aldehyde and epoxide were 
inseparable by column chromatography, so the crude mixture was re-dissolved in MeOH (15 ml) 
and NaBH4 (75 mg, 1.98 mmol) added to reduce the excess aldehyde. After stirring for 1 h at 
room temperature, the reaction was quenched with water and the mixture extracted with ether, 
the combined extracts being dried (Na2SO4) before the solvent was removed in vacuo. 
Chromatography on silica gel (Et2O: petroleum ether 1:49) afforded the title compound 10 (400 
mg, 38%) as a colourless oil. IR: νmax (Neat): 2955, 2929, 2886, 2857, 1471, 1464, 1254, 1106, 
1080, 840, 777 and 719 cm-1. NMR δH (400 MHz; CDCl3): 5.91 – 5.83 (2 H, m, alkene CH), 
5.67 (1 H, app. dq, J = 10.1, 2.0, alkene CH), 5.37 (1 H, app. dq, J = 10.3, 2.0, alkene CH), 3.63 
(1 H, d, J = 9.3, one of CH2OTBS), 3.48 (1 H, d, J = 9.3, one of CH2OTBS), 3.13 (1 H, dd, J = 
4.0, 2.9, epoxide CH), 2.66 – 2.64 (3 H, m, one of epoxide CH2 and ring CH2), 2.60 (1 H, dd, J 
5.1, 2.9, one of epoxide CH2), 0.90 (9 H, s, t-Bu), 0.05 (3 H, s, CH3) and 0.04 (3 H, s, CH3); δC 
(100 MHz; CDCl3): 127.6 (CH), 126.2 (CH), 126.1 (CH), 124.9 (CH), 68.6 (CH2), 55.2 (CH), 
44.3 (CH2), 41.8 (C), 27.0 (CH2), 25.8 (3 × CH3), 18.3 (C) and -5.5 (2 × CH3). MS-APCI: m/z 
(%) = 267 (M+H+, 100), 249 (28), 176 (8), 156 (13), 132 (22) and 115 (3). HRMS-APCI: m/z [M 
+ H]+ calcd for C15H27O2Si: 267.1780; found: 267.1771. 
[1-[2-Bromo-1-(tert-butyldimethylsilyloxy)ethyl]cyclohexa-2,5-dienyl]methanol (23). t-
Butyllithium (1.00 ml of 1.7 M solution in pentane, 1.70 mmol) was added to a solution of 
bromide 11 (196 mg, 0.850 mmol) in THF (10 ml) at -78 °C. After stirring for 10 minutes 
epoxide 10 (113 mg, 0.425 mmol) was added. The resulting solution was stirred for 15 minutes 
at -78 °C before BF3.THF (0.05 ml, 0.425 mmol) was added. After stirring for an additional 1 h, 
the reaction was quenched at -78 °C with saturated aqueous NH4Cl solution. The mixture was 
extracted with Et2O, the combined extracts being dried (Na2SO4) before the solvent was removed 
in vacuo. Chromatography on silica gel (Et2O: hexane 1:99) afforded the title compound 23 (94 
mg, 64%) as a colourless oil. IR: νmax (Neat): 3478, 3029, 2928, 2857, 1472, 1253, 1106, 837, 
777 and 655 cm-1. NMR: δH (400 MHz; CDCl3): 5.95 – 5.86 (2 H, m, alkene CH), 5.81 (1 H, 
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ddd, J = 10.4, 4.0, 2.0, alkene CH), 5.43 (1 H, ddd, J = 10.1, 4.1, 2.0, alkene CH), 4.01 (1 H, app. 
broad d, J = 10.5, CHOTBS), 3.72 (1 H, s, OH), 3.67 (1 H, d, J = 9.5, one of CH2OH), 3.58 (1 H, 
d, J = 9.5, one of CH2OH), 3.51 (1 H, dd, J = 10.5, 1.8, one of CH2Br), 3.26 (1 H, t, J = 10.5, one 
of CH2Br), 2.68 – 2.64 (2 H, m, ring CH2), 0.89 (9 H, s, t-Bu) and 0.05 (6 H, s, 2 × CH3); δC (100 
MHz; CDCl3): 127.4 (CH), 127.1 (CH), 126.6 (CH), 124.4 (CH), 76.5 (CH), 70.8 (CH2), 45.2 
(C), 37.9 (CH2), 27.2 (CH2), 25.8 (3 × CH3), 18.2 (C) and -5.6 (2 × CH3). MS-APCI: m/z (%) = 
349 (100), 347 (M+H+, 94), 331 (27), 329 (24), 217 (53), 215 (50), 199 (34), 197 (35), 158 (6), 
156 (13), 132 (18) and 117 (12). HRMS-APCI: m/z [M + H]+ calcd for C15H2879BrO2Si: 
347.1042; found: 347.1030. 
2-Bromo-1-[(1RS,3aSR,7aSR)-1-(2-bromophenyl)-1,3,3a,6,7,7a-hexahydroisobenzofuran-4-
yl]ethanone (18). t-Butyllithium (1.33 ml of 1.7 M solution in pentane, 2.26 mmol) was added to 
a solution of bromide 11 (261 mg, 1.13 mmol) in THF (10 ml) at -78 °C. After stirring for 10 
minutes epoxide 10 (155 mg, 0.58 mmol) was added. The resulting solution was stirred for 15 
minutes at -78 °C before BF3.THF (0.07 ml, 0.56 mmol) was added. After stirring for an 
additional 1 h, the reaction was quenched at -78 °C with saturated aqueous NH4Cl solution. The 
mixture was extracted with Et2O, the combined extracts being dried (Na2SO4) before the solvent 
was removed in vacuo. Chromatography on silica gel (Et2O: hexane 1:99) afforded an 
approximately 1:1 mixture of bromide 11 and compound 23 (157 mg) as a colourless oil. 
Trifluoromethanesulfonic acid (0.01 ml, 0.12 mmol) was added to a sample of the mixture of 
compounds 11 and 23 (51 mg) in CH2Cl2 (2 ml) at 0 °C. The resulting solution was warmed to 
room temperature and stirred for 15 minutes before a further portion of trifluoromethanesulfonic 
acid (0.01 ml, 0.12 mmol) was added. After stirring for an additional 10 minutes, the reaction 
was quenched by addition of saturated aqueous NaHCO3 solution. The crude mixture was 
extracted with CH2Cl2, the combined extracts being dried (Na2SO4) before the solvent was 
removed in vacuo. Chromatography on silica gel (Et2O: hexane 1:9) afforded the title compound 
18 (22 mg, 29%) as a colourless oil. NMR: δH (400 MHz; CDCl3): 7.56 – 7.51 (2 H, m, aryl CH), 
7.30 (1 H, app. td, J = 7.6, 1.0, aryl CH), 7.13 (1 H, app. td, J = 7.6, 1.6, aryl CH), 7.07 (1 H, 
app. dd, J = 5.3, 1.7, alkene CH), 5.31 (1 H, d, J = 4.8, CHO), 4.50 (1 H, dd, J = 9.2, 8.2, one of 
CH2O), 4.19 (2 H, s, CH2Br), 3.63 (1 H, app. dd, J = 9.0, 8.3, one of CH2O), 3.49 – 3.41 (1 H, m, 
ring junction CH), 2.80 (1 H, ddt, J = 13.2, 6.6, 4.8, ring junction CH), 2.32 (1 H, dtd, J = 19.7, 
5.4, 2.0, one of allylic CH2), 2.24 – 2.14 (1 H, broad m, one of allylic CH2), 1.08 (1 H, app, ddd, 
J = 24.9, 13.2, 5.2, one of CH2) and 0.90 – 0.82 (1 H, m, one of CH2); δC (100 MHz; CDCl3): 
192.1 (C=O), 143.6 (alkene CH), 138.7 (C), 137.3 (C), 132.3 (CH), 128.6 (CH), 128.2 (CH), 
127.0 (CH), 121.3 (C), 82.8 (CH), 72.0 (CH2), 38.4 (CH), 38.3 (CH), 29.7 (CH2), 25.8 (CH2) and 
19.2 (CH2). MS-APCI: m/z (%) = 403 (48), 401 (100), 399 (M+H+, 52), 385 (33), 383 (65), 381 
(34) and 219 (34). HRMS-APCI: m/z [M + 1]+ calcd for C16H1779Br2O2: 398.9595; found: 
398.9585. 
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